2.65
0.05 (1.92%)
| Previous Close | 2.60 |
| Open | 2.60 |
| Volume | 793,509 |
| Avg. Volume (3M) | 2,285,085 |
| Market Cap | 1,014,713,792 |
| Price / Earnings (TTM) | 24.09 |
| Price / Sales | 7.62 |
| Price / Book | 0.920 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2026 |
| Profit Margin | 39.69% |
| Operating Margin (TTM) | -10.90% |
| Diluted EPS (TTM) | 0.140 |
| Quarterly Revenue Growth (YOY) | 27.60% |
| Total Debt/Equity (MRQ) | 0.16% |
| Current Ratio (MRQ) | 27.80 |
| Operating Cash Flow (TTM) | 18.95 M |
| Levered Free Cash Flow (TTM) | -28.78 M |
| Return on Assets (TTM) | -2.42% |
| Return on Equity (TTM) | 4.59% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Cronos Group Inc. Common Share | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 2.0 |
| Average | 0.50 |
|
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 46.73% |
| % Held by Institutions | 14.32% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Chescapmanager Llc | 31 Dec 2025 | 7,942,737 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 02 Feb 2026 | Announcement | Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy |
| 09 Dec 2025 | Announcement | Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |